DOI:
10.1055/s-00034922
Arthritis und Rheuma
LinksClose Window
References
Baraliakos X. et al.
Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylo-sing spondylitis.
J Rheumatol 2007;
34: 510-515.
We do not assume any responsibility for the contents of the web pages of other providers.